Back
Day Range
$13.60
$13.78
52-Week Range
$12.72
$19.09
Volume
1,089,525
50D / 200D Avg
$14.27
/
$14.52
Prev Close
$13.53
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 9.3 | 0.4 |
| P/B | 1.3 | 2.9 |
| ROE % | 13.5 | 3.8 |
| Net Margin % | 25.3 | 3.9 |
| Rev Growth 5Y % | 0.9 | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Revenue grew 0.89% annually over 5 years — modest growth
Earnings declined -48.24% over the past year
ROE of 13.53% — decent returns on equity
Net margin of 25.33% shows strong profitability
Debt/Equity of 0.02 — conservative balance sheet
Generating 84.29M in free cash flow
Growth
Revenue Growth (5Y)
0.89%
Revenue (1Y)-6.16%
Earnings (1Y)-48.24%
FCF Growth (3Y)-30.82%
Quality
Return on Equity
13.53%
ROIC9.20%
Net Margin25.33%
Op. Margin23.05%
Safety
Debt / Equity
0.02
Current Ratio9.88
Interest Coverage0.00
Valuation
P/E Ratio
9.27
P/B Ratio1.27
EV/EBITDA6.80
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6.16% | Revenue Growth (3Y) | -13.23% |
| Earnings Growth (1Y) | -48.24% | Earnings Growth (3Y) | -31.15% |
| Revenue Growth (5Y) | 0.89% | Earnings Growth (5Y) | -13.16% |
| Profitability | |||
| Revenue (TTM) | 370.50M | Net Income (TTM) | 93.83M |
| ROE | 13.53% | ROA | 12.24% |
| Gross Margin | 78.54% | Operating Margin | 23.05% |
| Net Margin | 25.33% | Free Cash Flow (TTM) | 84.29M |
| ROIC | 9.20% | FCF Growth (3Y) | -30.82% |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 9.88 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 9.27 | P/B Ratio | 1.27 |
| P/S Ratio | 2.35 | PEG Ratio | -0.28 |
| EV/EBITDA | 6.80 | Dividend Yield | 0.00% |
| Market Cap | 869.92M | Enterprise Value | 580.61M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 370.50M | 394.82M | 492.05M | 454.27M | 357.57M |
| Net Income | 93.83M | 181.28M | 197.92M | 161.52M | 164.97M |
| EPS (Diluted) | 1.43 | 2.25 | 2.30 | 1.89 | 1.92 |
| Gross Profit | 290.97M | 317.07M | 411.34M | 380.79M | 303.97M |
| Operating Income | 85.39M | 112.53M | 195.66M | 197.85M | 167.48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 766.43M | 785.67M | 863.29M | 644.41M | 478.54M |
| Total Liabilities | 83.23M | 81.85M | 75.91M | 89.79M | 62.74M |
| Shareholders' Equity | 683.20M | 703.81M | 787.37M | 554.62M | 415.80M |
| Total Debt | 13.24M | 7.82M | 9.02M | 4.96M | 4.52M |
| Cash & Equivalents | 302.54M | 155.33M | 144.41M | 97.54M | 68.14M |
| Current Assets | 698.62M | 714.45M | 845.33M | 629.37M | 470.11M |
| Current Liabilities | 70.74M | 69.85M | 64.14M | 82.02M | 51.85M |